Epithelial-to-mesenchymal transition is an active process in the large airways of patients with asthma-COPD overlap and partially abrogated by inhaled corticosteroid treatment: a bronchoscopy endobronchial biopsy study.
- DOI
- 10.3389/fimmu.2025.1531279
- Published
- 2025
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2025.1531279,
title = {Epithelial-to-mesenchymal transition is an active process in the large airways of patients with asthma-COPD overlap and partially abrogated by inhaled corticosteroid treatment: a bronchoscopy endobronchial biopsy study.},
author = {Dey S and Lu W and Pathinayake PS and Waters M and Haug G and Larby J and Weber HC and Wark PAB and Eapen MS and Sohal SS},
year = {2025},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2025.1531279},
url = {https://doi.org/10.3389/fimmu.2025.1531279}
}RIS
TY - JOUR TI - Epithelial-to-mesenchymal transition is an active process in the large airways of patients with asthma-COPD overlap and partially abrogated by inhaled corticosteroid treatment: a bronchoscopy endobronchial biopsy study. AU - Dey S AU - Lu W AU - Pathinayake PS AU - Waters M AU - Haug G AU - Larby J AU - Weber HC AU - Wark PAB AU - Eapen MS AU - Sohal SS PY - 2025 JO - Frontiers in immunology DO - 10.3389/fimmu.2025.1531279 UR - https://doi.org/10.3389/fimmu.2025.1531279 ER -
APA
S, D., W, L., PS, P., M, W., G, H., J, L., HC, W., PAB, W., MS, E., & SS, S. (2025). Epithelial-to-mesenchymal transition is an active process in the large airways of patients with asthma-COPD overlap and partially abrogated by inhaled corticosteroid treatment: a bronchoscopy endobronchial biopsy study.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2025.1531279
Source records
- pubmed · retrieved 2026-09-26T12:19:10.225Z